California Nanotechnologies (CNO) AI Stock Analysis

• Market Cap: C$26.16M
• Dividend Yield: N/A
• Average Volume (3M): 32.41K
• Price to Earnings (P/E): 86.5
• Beta (1Y): 2.65
• Revenue Growth: 90.55%
• EPS Growth: -127.18%
• Country: CA
• Employees: N/A
• Sector: Technology
• Sector Strength: 91
• Industry: Chemicals - Specialty
• EPS (TTM): N/A
• Shares Outstanding: 46,714,287
• 10 Day Avg. Volume: 40,308
• 30 Day Avg. Volume: 32,406
• PEG Ratio: -0.28
• Price to Book (P/B): 7.72
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 24.64
• Enterprise Value/Market Cap: 0.79
• Enterprise Value/Revenue: 0.85
• Enterprise Value/Gross Profit: 4.51
• Enterprise Value/Ebitda: 5.67
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: C$0.50 ▼(-10.71%Downside)

California Nanotechnologies' score reflects strong corporate developments and revenue growth, tempered by valuation challenges and technical indicators showing a neutral trend. While corporate events suggest a positive long-term outlook, immediate financial metrics and technical analysis indicate caution.

California Nanotechnologies Business Overview & Revenue Model

Company Description

California Nanotechnologies (CNO) is a technology company specializing in the development and production of advanced materials through the use of nanotechnology. The company serves sectors such as aerospace, automotive, sports and recreation, and defense by providing innovative solutions that enhance the performance and durability of materials. Key products and services include the fabrication of nanostructured components and materials that offer superior strength, wear resistance, and thermal stability.

How the Company Makes Money

California Nanotechnologies generates revenue through the sale of its advanced materials and components to various industries including aerospace, automotive, and defense. The company's revenue model is centered around manufacturing and delivering customized nanostructured products that meet specific client needs. Additionally, CNO engages in research and development projects funded by partnerships with industry leaders and government agencies, contributing to its earnings. The company's ability to innovate and deliver high-performance materials attracts a steady stream of clients looking to enhance the quality and capability of their products.

California Nanotechnologies Financial Statement Overview

Summary

California Nanotechnologies shows promising revenue growth and improving equity positions, but profitability challenges and high leverage present potential risks. Strong cash flow generation provides a solid foundation for future financial stability.

Income Statement

The company has shown strong revenue growth, with significant increases in total revenue each year, indicating a healthy expansion trajectory. However, profitability metrics such as net profit margin are weak due to a negative net income in the latest period, which impacts the overall score. Gross profit margin is robust, reflecting efficient cost management, but the net loss in the TTM period is a concern.

Balance Sheet

The balance sheet reveals high leverage, with a substantial debt-to-equity ratio due to negative equity in previous years. The equity ratio has improved but remains low, showing risk in financial stability. The recent positive stockholders' equity is a positive sign, indicating improved financial health.

Cash Flow

Cash flow performance is strong, with positive free cash flow growth and a high operating cash flow to net income ratio, which indicates good cash generation relative to income. However, fluctuations in financing cash flow might indicate volatility in funding strategies.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	6.22M	3.34M	1.82M	1.36M	1.06M
Gross Profit	4.59M	2.33M	669.57K	514.32K	439.97K
EBITDA	780.97K	753.02K	337.91K	314.81K	10.77K
Net Income	-158.33K	381.68K	79.76K	200.60K	-161.40K
Balance Sheet
Total Assets	5.50M	2.36M	1.41M	1.22M	587.40K
Cash, Cash Equivalents and Short-Term Investments	533.85K	841.35K	294.13K	65.11K	25.29K
Total Debt	1.62M	1.21M	1.94M	2.15M	1.94M
Total Liabilities	3.19M	2.21M	2.70M	2.58M	2.24M
Stockholders Equity	2.32M	145.97K	-1.29M	-1.36M	-1.66M
Cash Flow
Free Cash Flow	797.00K	89.98K	604.26K	45.29K	33.20K
Operating Cash Flow	2.92M	104.28K	717.01K	54.97K	33.20K
Investing Cash Flow	-2.11M	-14.30K	-112.75K	―	0.00
Financing Cash Flow	-1.12M	535.33K	-387.83K	―	-62.52K

California Nanotechnologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.56
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.57, below the 50-day MA of 0.57, and below the 200-day MA of 0.87, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.37 is Neutral, neither overbought nor oversold. The STOCH value of 6.55 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CNO.

California Nanotechnologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	59 Neutral	€3.11B	11.82	-8.77%	2.79%	5.08%	-50.65%
GMG	58 Neutral	C$65.56M	―	-72.52%	―	-9.37%	22.80%
CNO	56 Neutral	C$26.16M	86.54	-13.57%	―	90.55%	-127.18%
HG	53 Neutral	C$64.04M	―	-96.25%	―	203.80%	16.89%
NANO	45 Neutral	C$82.51M	―	-51.47%	―	―	13.34%
IZ	41 Neutral	C$424.07K	100.00		―	109.13%	―

California Nanotechnologies Corporate Events

California Nanotechnologies Reports Record FY2025 Revenue Amid Strategic Expansion

California Nanotechnologies reported a record annual revenue of US$6.224 million for FY2025, marking an 87% increase year-over-year, driven by manufacturing services and SPS equipment sales. Despite a net loss due to non-cash charges from share purchase warrants, the company is strategically investing in its Santa Ana facility to enhance manufacturing capabilities and secure recurring commercial orders, positioning itself for sustainable long-term growth.

California Nanotechnologies Secures Key Orders and ISO Certification

California Nanotechnologies Corp. has secured two purchase orders from Oerlikon Metco and AbTech Industries, marking a significant step in its transition from a research and development service provider to a commercial production entity. The company has also achieved ISO 9001 certification, which will enable it to bid for larger commercial contracts. These developments are expected to enhance Cal Nano’s market position and revenue diversification, despite a temporary slowdown in R&D activity with a green steel customer.